201 related articles for article (PubMed ID: 38003678)
1. Epigenetic Dysregulation and Its Correlation with the Steroidogenic Machinery Impacting Breast Pathogenesis: Data Mining and Molecular Insights into Therapeutics.
Manna PR; Yang S; Reddy PH
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003678
[TBL] [Abstract][Full Text] [Related]
2. Hormonal and Genetic Regulatory Events in Breast Cancer and Its Therapeutics: Importance of the Steroidogenic Acute Regulatory Protein.
Manna PR; Ahmed AU; Molehin D; Narasimhan M; Pruitt K; Reddy PH
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740335
[TBL] [Abstract][Full Text] [Related]
3. Expression and Function of StAR in Cancerous and Non-Cancerous Human and Mouse Breast Tissues: New Insights into Diagnosis and Treatment of Hormone-Sensitive Breast Cancer.
Manna PR; Ramachandran S; Pradeepkiran JA; Molehin D; Castro-Piedras I; Pruitt K; Ganapathy V; Reddy PH
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614200
[TBL] [Abstract][Full Text] [Related]
4. Genomic Profiling of the Steroidogenic Acute Regulatory Protein in Breast Cancer: In Silico Assessments and a Mechanistic Perspective.
Manna PR; Ahmed AU; Yang S; Narasimhan M; Cohen-Tannoudji J; Slominski AT; Pruitt K
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31060224
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the steroidogenic acute regulatory protein in breast cancer: Regulation by histone deacetylase inhibition.
Manna PR; Ahmed AU; Vartak D; Molehin D; Pruitt K
Biochem Biophys Res Commun; 2019 Feb; 509(2):476-482. PubMed ID: 30595381
[TBL] [Abstract][Full Text] [Related]
6. Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells.
Varga K; Hollósi A; Pászty K; Hegedűs L; Szakács G; Tímár J; Papp B; Enyedi Á; Padányi R
BMC Cancer; 2018 Oct; 18(1):1029. PubMed ID: 30352569
[TBL] [Abstract][Full Text] [Related]
7. The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: Current findings and future perspectives.
Sukocheva OA; Lukina E; Friedemann M; Menschikowski M; Hagelgans A; Aliev G
Semin Cancer Biol; 2022 Jul; 82():35-59. PubMed ID: 33301860
[TBL] [Abstract][Full Text] [Related]
8. Gene Expression Profiling of Multiple Histone Deacetylases (
Teena R; Dhamodharan U; Ali D; Rajesh K; Ramkumar KM
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33096729
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of estrogen signaling in breast cancer.
Hervouet E; Cartron PF; Jouvenot M; Delage-Mourroux R
Epigenetics; 2013 Mar; 8(3):237-45. PubMed ID: 23364277
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.
Oh S; Ko JY; Oh C; Yoo KH
Adv Exp Med Biol; 2017; 1026():287-313. PubMed ID: 29282690
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterisation of cell line models for triple-negative breast cancers.
Grigoriadis A; Mackay A; Noel E; Wu PJ; Natrajan R; Frankum J; Reis-Filho JS; Tutt A
BMC Genomics; 2012 Nov; 13():619. PubMed ID: 23151021
[TBL] [Abstract][Full Text] [Related]
12. Changes of N6-methyladenosine modulators promote breast cancer progression.
Wu L; Wu D; Ning J; Liu W; Zhang D
BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
[TBL] [Abstract][Full Text] [Related]
13. Genomic pathway analysis reveals that EZH2 and HDAC4 represent mutually exclusive epigenetic pathways across human cancers.
Cohen AL; Piccolo SR; Cheng L; Soldi R; Han B; Johnson WE; Bild AH
BMC Med Genomics; 2013 Sep; 6():35. PubMed ID: 24079712
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-induced hypomethylation and overexpression of YAP1 facilitate breast cancer cell growth and survival.
Muhammad JS; Guimei M; Jayakumar MN; Shafarin J; Janeeh AS; AbuJabal R; Eladl MA; Ranade AV; Ali A; Hamad M
Neoplasia; 2021 Jan; 23(1):68-79. PubMed ID: 33242831
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer.
Jiang CF; Shi ZM; Li DM; Qian YC; Ren Y; Bai XM; Xie YX; Wang L; Ge X; Liu WT; Zhen LL; Liu LZ; Jiang BH
Mol Cancer; 2018 Apr; 17(1):83. PubMed ID: 29685157
[TBL] [Abstract][Full Text] [Related]
16. Estradiol-independent modulation of breast cancer transcript profile by 17beta-hydroxysteroid dehydrogenase type 1.
Aka JA; Calvo EL; Lin SX
Mol Cell Endocrinol; 2017 Jan; 439():175-186. PubMed ID: 27544780
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
[TBL] [Abstract][Full Text] [Related]
20. Steroidogenic acute regulatory protein transcription is regulated by estrogen receptor signaling in largemouth bass ovary.
Prucha MS; Martyniuk CJ; Doperalski NJ; Kroll KJ; Barber DS; Denslow ND
Gen Comp Endocrinol; 2020 Jan; 286():113300. PubMed ID: 31678557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]